Blog Archives

Methodology for a Symptomatic Impact Study Using a Portable Essential Tremor Monitor to Direct Therapeutic Interventions

P Vittal, C Pulliam, C Goetz, J Jankovic, J Ramirez-Castaneda, D Heldman
18th International Congress of Parkinson’s Disease and Movement Disorders, Stockholm, Sweden, 2014

Read more ›



PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps

VIEW PRESS RELEASE

15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with mobile apps strategically aligns with growing trends in domestic and international healthcare landscapes regarding accessibility,

Read more ›



Tremor retrainment as therapeutic strategy in psychogenic (functional) tremor

A. Espay, M. Edwards, G. Oggioni, N. Phielipp, B. Cox, H. Gonzalez-Usigli, C. Pecina, D. Heldman, J. Mishra, A. Lang
Parkinsonism Relat Disord. 2014;20(6):647–50.

Read more ›



PRESS RELEASE: GLNT Awarded Patent For Technology To Treat Parkinson’s Disease With Brain Stimulation During Sleep

VIEW PRESS RELEASE [PDF]

22 JUL 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of stimulating the brain during sleep to treat movement disorder symptoms.

Read more ›



PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study to Develop Intelligent Algorithms for Programming Deep Brain Stimulation in Parkinson’s

VIEW PRESS RELEASE [PDF]

22 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for Parkinson’s disease.   The study is being funded by a $283,828 Phase I Small Business Innovative Research grant from the National Institutes of Health,

Read more ›



PRESS RELEASE: Great Lakes NeuroTechnologies’ Kinesia Technology Receives TGA Approval for Parkinson’s Assessment in Australia

VIEW PRESS RELEASE [PDF]

9 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line [ http://glneurotech.com/kinesia/ ] includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor,

Read more ›



PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess motor symptoms in response to new deep brain stimulation (DBS) and pharmaceutical therapies. 

Read more ›



Acute effects of passive leg cycling on upper extremity tremor and bradykinesia in Parkinson’s disease

A. Ridgel, M. Muller, C. Kim, E. Fickes, T. Mera
Phys Sportsmed. 2011 Sep;39(3):83-93

Read more ›



Upper-extremity stroke therapy task discrimination using motion sensors and electromyography

J. Giuffrida, A. Lerner, R. Steiner, J. Daly
IEEE Trans Neural Syst Rehabil Eng. 2008 Feb;16(1):82-90

Read more ›



Press Release: CLEVEMED AWARDED $896,000 NIH GRANT TO HELP STROKE PATIENTS RECOVER LOST MOTOR FUNCTION

VIEW PRESS RELEASE [PDF]

CLEVELAND, OHIO, October 24, 2006 – Cleveland Medical Devices Inc. (CleveMed) has been awarded a $896,000 Phase II grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) to continue the development and clinical assessment of an Untethered Home Therapy System (UHTS) to help stroke patients recover upper extremity motor function through home-based rehabilitation therapy and monitoring.

Read more ›



Top